Your browser doesn't support javascript.
loading
Pooled sputum testing by Xpert® MTB/RIF Ultra for active tuberculosis case finding among high-risk groups in a low-incidence area: a prospective study.
Ma, Zichun; Zhang, Lijie; Li, Shanshan; Shang, Yuanyuan; Wang, Yufeng; Xue, Zhongtan; Shu, Wei; Sun, Yuxian; Gao, Xinghui; Liu, Yuhong; Gao, Jingtao; Gnanashanmugam, Devasena; Tang, Yi-Wei; Li, Liang; Pang, Yu.
  • Ma Z; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Zhang L; Clinical Center on TB Control, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Li S; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Shang Y; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Wang Y; Innovation Alliance on Tuberculosis Diagnosis and Treatment, Beijing, P. R. China.
  • Xue Z; Innovation Alliance on Tuberculosis Diagnosis and Treatment, Beijing, P. R. China.
  • Shu W; Clinical Center on TB Control, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Sun Y; Innovation Alliance on Tuberculosis Diagnosis and Treatment, Beijing, P. R. China.
  • Gao X; Cepheid, Danaher Diagnostic Platform, Shanghai, P. R. China.
  • Liu Y; Clinical Center on TB Control, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Gao J; Clinical Center on TB Control, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Gnanashanmugam D; Cepheid, Danaher Diagnostic Platform, Shanghai, P. R. China.
  • Tang YW; Cepheid, Danaher Diagnostic Platform, Shanghai, P. R. China.
  • Li L; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
  • Pang Y; Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P. R. China.
Infect Dis (Lond) ; 56(6): 434-440, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38380873
ABSTRACT

BACKGROUND:

Early detection and treatment of tuberculosis (TB) are of great importance to stop its spread. However, optimising the active case findingstrategy is critical to improving its feasibility in regions where TB is epidemic.

METHOD:

The different pooled ratios between TB-positive and TB-negative sputum specimens were evaluated and a pooling ratio of 51 was used for the active case finding screening by Xpert MTB/RIF Ultra among high-risk groups in Beijing.

RESULTS:

The sensitivity of pooling ratio at 51 was 97.5% (39/40). Between October 2022 and March 2023, among 17,681 participants, 1729 metthe active case finding criteria and were screened by 350 51 sputum pools by Xpert MTB/RIF Ultra. Four pools (1.1%) tested positive and were further confirmed as definite active TB cases. In our study population with high TB incidence (231/100,000), the cost for detection of individual patients was reduced by 77.4% at a 51 pooling ratio.

CONCLUSIONS:

pooled sputum testing at a suitable ratio using Xpert MTB/RIF Ultra provides a rapid, efficient, and cost-effective method for active TB case finding among high-risk groups in a low-incidence area.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article